Piramal Pharma Solutions Wins CMO Leadership Award
Piramal Pharma Solutions was recognized as a winner at the CMO Leadership Award 2018.
The event was held on March 21st, 2018 in New York during the Drug, Chemical and Associated Technologies Association (DCAT) week. Piramal was recognized across all six categories - Capabilities, Compatibility, Expertise, Quality, Reliability, and Service.
Vivek Sharma, chief executive officer at Piramal Pharma Solutions, said, "We are delighted to be recognized again at the CMO Leadership Awards, this is the sixth consecutive year that we have won. To be one of the few service providers to be recognized in all six categories is humbling, and I would like to congratulate the entire PPS team for their efforts. I also want to thank our customers for their continued trust in us, as we seek to serve the needs of the end patients."
The 7th edition of the CMO Leadership Awards, conducted by Life Science Leader magazine, provides industry veterans with accurate and reliable customer feedback to assist them in choosing a reputable partner for their development and manufacturing needs. The recipients are evaluated by the customers they have actually worked with.
Piramal Pharma Solutions is the Contract Development and Manufacturing arm of Piramal Group with operations across North America, Europe and Asia. Their development centers and manufacturing sites across the globe have a pool of over 700 scientists committed to research & development programs.
Looking for chemical products? Let suppliers reach out to you!
2026-07-06
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Piramal to invest $80 million to expand US sterile injectables plant
-
Celebrating Excellence in the Pharma Industry!
-
ECHEMI Ranked on the list of 2022 Global Top 100 internet companies in China
-
ECHEMI Won The Honor of ‘2021 China Industrial Internet Top 100’
-
Three innovative products of BASF won the European BSB Award
-
the 3rd 'Colour for Love' Rural Support Award for Chinese College Students
-
The GLP-1 Sweet Shot in India’s Diabetic Gut
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
Recommend Reading
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
Roche Keeps German Diagnostics Investment
-
India Raises Cancer Drug Price Caps by 50%
-
This Week's Styrene Market Weakens and Declines (4.20-4.24)
-
This week, the caustic soda price was weak in China (4.20-4.24)
-
Polyester Bottle Flakes Remain Highly Volatile This Week; Weekly Average Price Rises Compared to Previous Week
-
This Week's PVC Market in China: Bottoming Out with Low-level Fluctuations, Intensifying Supply and Demand Competition
-
EFSA Unable to Conclude on Full-Scope Safety of Genetically Modified Oilseed Rape LBFLFK